Diseases, Conditions, Syndromes

Study confirms effectiveness of bivalent COVID-19 vaccine

A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less abundantly, according to ...

HIV & AIDS

Trim the sugar: New HIV vaccine design improves immune response

A new HIV vaccine from Scripps Research has shown a significantly improved ability to neutralize the virus in preclinical tests, and it will soon be studied in healthy people who volunteer to participate in clinical trials.

Diseases, Conditions, Syndromes

Chlamydia vaccine shows promise in early trial

A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).

page 13 from 40